Zafirlukast Tablet, Coated
Product Images NDC 42291-970

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Zafirlukast (NDC 42291-970). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

60 (970 60)

60 (970 60)
Zafirlukast Tablets 10 mg coated oral tablets packaged as 60 tablets. The label shows the AvKARE brand with NDC 42291-970-60. Usage warnings instruct to follow the accompanying medication guide and caution about drug interactions, storage at controlled room temperature, and moisture protection.*
FDA Label Image

60 (971 60)

60 (971 60)
Packaging label for Zafirlukast Tablets 20 mg by AvKARE. The label indicates 60 coated tablets for oral use. It includes warnings, storage instructions, manufacturer details, and the NDC 42291-971-60. The label displays the proprietary name, strength, and Rx only status.*
FDA Label Image

Image (Fe744b24 1463 4eb5 A985 C0e9febc6ebd 01)

Image (Fe744b24 1463 4eb5 A985 C0e9febc6ebd 01)
Chemical structure diagram of the active ingredient zafirlukast.*
FDA Label Image

Graph (Fe744b24 1463 4eb5 A985 C0e9febc6ebd 02)

Graph (Fe744b24 1463 4eb5 A985 C0e9febc6ebd 02)
A line graph showing mean β2-agonist use (puffs per day) over a 14-week trial period. The graph compares three groups: placebo, Zafirlukast 20 mg twice daily, and Cromolyn sodium 1600 μg four times a day. The vertical axis represents β2-agonist use in puffs per day; the horizontal axis represents trial weeks from 0 to 14.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.